Erasca, Inc. Capital Expenditures
Erasca, Inc. (ERAS) reported Capital Expenditures of $44.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-11
- Erasca, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $8.00K, a 73.33% decline year-over-year.
- Erasca, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $36.00K, a 56.63% decline year-over-year.
- Erasca, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $9.00K.
- Erasca, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $6.00K, a 20.00% increase year-over-year.
- Erasca, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $128.00K, a 113.33% increase from fiscal 2024.
- Erasca, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $60.00K, a 96.62% decline from fiscal 2023.
- Erasca, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $1.77M, a 87.80% decline from fiscal 2022.
- Erasca, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $14.55M, a 29.86% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $44.00K 10-Q · filed 2026-08-11 | $53.00K derived: sum of 3 quarters · filed 2026-08-11 | $59.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $36.00K 10-Q · filed 2026-05-11 | $45.00K derived: sum of 2 quarters · filed 2026-05-11 | $51.00K derived: sum of 3 quarters · filed 2026-05-11 | $81.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $15.00K derived: sum of 2 quarters · filed 2026-03-12 | $45.00K derived: sum of 3 quarters · filed 2026-08-11 | $128.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $36.00K derived: sum of 2 quarters · filed 2026-08-11 | $119.00K 10-Q · filed 2025-11-12 | $119.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $113.00K 10-Q · filed 2026-08-11 | $113.00K derived: sum of 3 quarters · filed 2026-08-11 | $118.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $83.00K 10-Q · filed 2026-05-11 | $83.00K derived: sum of 2 quarters · filed 2026-05-11 | $88.00K derived: sum of 3 quarters · filed 2026-05-11 | $101.00K derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $5.00K derived: sum of 2 quarters · filed 2026-03-12 | $18.00K derived: sum of 3 quarters · filed 2026-03-12 | $60.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $18.00K derived: sum of 2 quarters · filed 2025-11-12 | $60.00K 10-Q · filed 2025-11-12 | $142.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $55.00K 10-Q · filed 2025-08-12 | $137.00K derived: sum of 3 quarters · filed 2025-08-12 | $377.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $42.00K 10-Q · filed 2025-05-13 | $124.00K derived: sum of 2 quarters · filed 2025-05-13 | $364.00K derived: sum of 3 quarters · filed 2025-05-13 | $611.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $322.00K derived: sum of 2 quarters · filed 2025-03-20 | $569.00K derived: sum of 3 quarters · filed 2025-03-20 | $1.77M 10-K · filed 2025-03-20 |
| 2023-09-30 | $240.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $487.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.69M 10-Q · filed 2024-11-12 | $2.56M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $247.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $1.45M 10-Q · filed 2024-08-12 | $2.32M derived: sum of 3 quarters · filed 2024-08-12 | $4.11M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $1.21M 10-Q · filed 2024-05-08 | $2.07M derived: sum of 2 quarters · filed 2024-05-08 | $3.86M derived: sum of 3 quarters · filed 2024-05-08 | $8.42M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $864.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $2.66M derived: sum of 2 quarters · filed 2024-03-27 | $7.21M derived: sum of 3 quarters · filed 2024-03-27 | $14.55M 10-K · filed 2024-03-27 |
| 2022-09-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $6.35M derived: sum of 2 quarters · filed 2023-11-09 | $13.69M 10-Q · filed 2023-11-09 | $19.52M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $4.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $11.89M 10-Q · filed 2023-08-10 | $17.73M derived: sum of 3 quarters · filed 2023-08-10 | $22.40M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $7.34M 10-Q · filed 2023-05-15 | $13.17M derived: sum of 2 quarters · filed 2023-05-15 | $17.84M derived: sum of 3 quarters · filed 2023-05-15 | $18.42M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $10.50M derived: sum of 2 quarters · filed 2023-03-23 | $11.08M derived: sum of 3 quarters · filed 2023-03-23 | $11.21M 10-K · filed 2023-03-23 |
| 2021-09-30 | $4.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $5.25M derived: sum of 2 quarters · filed 2022-11-09 | $5.38M 10-Q · filed 2022-11-09 | $5.40M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $579.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $701.00K 10-Q · filed 2022-08-11 | $726.00K derived: sum of 3 quarters · filed 2022-08-11 | $875.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $122.00K 10-Q · filed 2022-05-12 | $147.00K derived: sum of 2 quarters · filed 2022-05-12 | $296.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $174.00K derived: sum of 2 quarters · filed 2022-03-24 | $947.00K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $922.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $773.00K 10-Q · filed 2021-08-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |